Top compounds associated with response to LGALS14


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA momelotinib CTRPv2 pan-cancer AAC 0.15 7e-06
mRNA Cytarabine GDSC1000 pan-cancer AAC -0.15 8e-06
mRNA manumycin A CTRPv2 pan-cancer AAC 0.14 9e-06
mRNA VER-155008 CTRPv2 pan-cancer AAC 0.15 9e-06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA JW-55 CTRPv2 pan-cancer AAC 0.31 2e-05
mRNA BRD-K45681478 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA A-804598 CTRPv2 pan-cancer AAC 0.19 2e-05
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.15 2e-05
Download CSV